We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
-$25.3M
Cap. Flow
-$26.9M
Cap. Flow %
-15.18%
Top 10 Hldgs %
37.78%
Holding
91
New
22
Increased
14
Reduced
14
Closed
30

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.08M
2
SNY icon
Sanofi
SNY
+$3.58M
3
CI icon
Cigna
CI
+$2.81M
4
ABBV icon
AbbVie
ABBV
+$2.69M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$2.25M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$8.2M
2
MDCO
Medicines Co
MDCO
+$4.45M
3
SHPG
Shire pic
SHPG
+$3.71M
4
WBA
Walgreens Boots Alliance
WBA
+$2.91M
5
MRK icon
Merck
MRK
+$2.87M

Sector Composition

Rank Sector Weight
1 Healthcare 69.67%
2 Financials 2.79%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
76
CALL
Viatris
VTRS
$18.7B
– –
-25,000
Closed -$975K
WBA
77
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-25,000
Closed -$2.08M
WBA
78
DELISTED
Walgreens Boots Alliance
WBA
– –
-35,000
Closed -$2.91M
MDRX
79
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-150,000
Closed -$1.9M
ZYNE
80
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-50,000
Closed -$1M
LHCG
81
DELISTED
LHC Group LLC
LHCG
– –
-35,000
Closed -$1.89M
AGTC
82
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-75,000
Closed -$518K
TVTY
83
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-75,000
Closed -$2.18M
RARX
84
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-50,000
Closed -$1.06M
MDCO
85
CALL
DELISTED
Medicines Co
MDCO
– –
-25,000
Closed -$1.22M
ALDR
86
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-75,000
Closed -$1.56M
ELGX
87
DELISTED
Endologix Inc
ELGX
– –
-15,000
Closed -$1.09M
MZOR
88
DELISTED
Mazor Robotics Ltd.
MZOR
– –
-58,000
Closed -$1.73M
IPXL
89
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-100,000
Closed -$1.26M
BIVV
90
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-25,000
Closed -$1.36M
OMED
91
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-50,000
Closed -$461K
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2017 Portfolio in Review

As of Q2 2017, Iguana Healthcare Management held 91 positions worth $177M, down 13% from $202M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management withdrew a net $26.9M in Q2 2017, closing 30 positions and reducing 14 holdings. Its most notable exit was Amgen, an estimated $8.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 66% a quarter earlier, followed by Financials and Energy.

Against the trend, Iguana Healthcare Management opened a new position in Eli Lilly worth $4.12M.

  • Iguana Healthcare Management's largest Q2 2017 buy was Eli Lilly: 50,000 shares worth $4.12M.
  • Iguana Healthcare Management added most to Allergan plc in Q2 2017, an estimated $1.76M increase.
  • Iguana Healthcare Management's biggest Q2 2017 reduction was Medicines Co, cutting an estimated $4.45M.
  • Iguana Healthcare Management fully exited Amgen in Q2 2017, selling an estimated $8.2M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $177M portfolio in Q2 2017.
  • Iguana Healthcare Management opened 22 new positions and closed 30 in Q2 2017.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $177M.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.